The current survival rate of Idiopathic Pulmonary Fibrosis (IPF) is as low as some of the most devastating cancers. Thanks to research, recent advances in new treatments are helping to slow the progression of the disease in some cases.
While this is promising, more research is desperately needed to better understand this complex disease so we can drive further progress of treatments, improve the late rate of diagnosis, support psychological management and search for a cure.
Bill, lives with IPF
Research awards and grants
Our IPF research awards and grants encourage early career and senior researchers and clinicians to undertake dedicated research into the diagnosis, treatment and management of IPF. Find out more about our research awards program and how to apply for funding.
Centre for Research Excellence – Pulmonary Fibrosis
Lung Foundation Australia is proud to be a founding partner of the Centre for Research Excellence – Pulmonary Fibrosis (CRE-PF), a comprehensive and integrated clinical research program that aims to change the approach to Pulmonary Fibrosis (PF) care and treatment in Australia.
Fact sheet: IPF
This fact sheet provides a brief overview of Idiopathic Pulmonary Fibrosis (IPF) and its symptoms, causes, diagnosis, treatment and management.View more
Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Fibrosis
“Who knows what research may provide for us in the years ahead, and my objective is to take every step I can to ensure best…Read more